Dr. James K. Bazemore Jr., MD

Dr. Bazemore practices at Nephrology and Hypertension Medical Associates in Savannah, Georgia.

Dr. Bazemore's NPI, 1265435564, was assigned on May 31, 2005. Dr. Bazemore graduated from American University of the Caribbean School of Medicine in 1985. Dr. Bazemore holds Georgia license 037953.

Dr. Bazemore's primary practice is Nephrology and Hypertension Medical Associates, at 1115 Lexington Ave, Savannah, GA 31404 in Chatham County. The practice phone is (912) 354-4813.

Dr. Bazemore's primary practice is Nephrology and Hypertension Medical Associates in Savannah, Georgia. Dr. Bazemore is also affiliated with Memorial Health University Medical Center. The medical group on file is Nephrology & Hypertension Medical Associates. Dmand AI also links Dr. Bazemore to 4 more hospitals, 3 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bazemore practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bazemore's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bazemore is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Bazemore's licenses on file in 4 states: Georgia, South Carolina, Alabama and Iowa.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Bazemore treats.

CMS data shows 1,680 Medicare services from Dr. Bazemore across 11 procedure codes in 2024, for 378 Medicare patients. Medicare paid $145,490 for them.

CMS counts 378 Medicare patients who saw Dr. Bazemore in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 3.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bazemore's median patient age at 69, with 46% women.

In 2024, Dr. Bazemore wrote 764 Medicare Part D claims for 162 patients. 85% of them were for generic drugs. CMS names the drug for 596 of them, across 22 drugs with 11 or more claims each, at $84,708 in total drug cost. In 2023, CMS named 577 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bazemore for performance year 2024, reported individually. Dr. Bazemore accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 147 general payments to Dr. Bazemore from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Amgen Inc. paid the most, $445.

Dmand AI lists 1 award for Dr. Bazemore, most recently CMS Stage 1 2012 in 2012.

Dr. Bazemore graduated from American University of the Caribbean School of Medicine in 1985. Dr. Bazemore is a member of RPA.

Dr. Bazemore is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.